ArticleLupus science & medicine2022

Low-dose belimumab for patients with systemic lupus erythematosus at low disease activity: protocol for a multicentre, randomised, double-blind, placebo-controlled clinical trial.

Fangfang Sun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.